J3401 Vyjuvek 5x10^9pfu/ml, 0.1 ml

Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 25 units per day (practitioner), rationale: CMS Policy